SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Wintrust Financial Corp – ‘10-Q’ for 3/31/16 – ‘EX-10.2’

On:  Monday, 5/9/16, at 5:24pm ET   ·   For:  3/31/16   ·   Accession #:  1015328-16-344   ·   File #:  1-35077

Previous ‘10-Q’:  ‘10-Q’ on 11/9/15 for 9/30/15   ·   Next:  ‘10-Q’ on 8/8/16 for 6/30/16   ·   Latest:  ‘10-Q’ on 5/9/24 for 3/31/24   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/09/16  Wintrust Financial Corp           10-Q        3/31/16  114:28M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   2.01M 
 2: EX-10.1     Material Contract                                   HTML     70K 
 3: EX-10.2     Material Contract                                   HTML     58K 
 4: EX-10.3     Material Contract                                   HTML     71K 
 5: EX-10.4     Material Contract                                   HTML     70K 
 6: EX-31.1     Certification -- §302 - SOA'02 -- exhibit311        HTML     42K 
 7: EX-31.2     Certification -- §302 - SOA'02 -- exhibit312        HTML     42K 
 8: EX-32.1     Certification -- §906 - SOA'02 -- exhibit321        HTML     38K 
15: R1          Document and Entity Information                     HTML     58K 
16: R2          Consolidated Statements Of Condition (Unaudited)    HTML    149K 
17: R3          Consolidated Statements Of Condition (Unaudited)    HTML     63K 
                (Parenthetical)                                                  
18: R4          Consolidated Statements Of Income (Unaudited)       HTML    162K 
19: R5          Consolidated Statements Of Comprehensive Income     HTML    101K 
                (Unaudited)                                                      
20: R6          Consolidated Statements Of Changes In               HTML     88K 
                Shareholders' Equity (Unaudited)                                 
21: R7          Consolidated Statements Of Cash Flows (Unaudited)   HTML    158K 
22: R8          Basis of Presentation                               HTML     41K 
23: R9          Recent Accounting Developments                      HTML     62K 
24: R10         Business Combinations                               HTML     76K 
25: R11         Cash and Cash Equivalents                           HTML     40K 
26: R12         Investment Securities                               HTML    332K 
27: R13         Loans                                               HTML    129K 
28: R14         Allowance for Loan Losses, Allowance for Losses on  HTML   1.27M 
                Lending-Related Commitments and Impaired Loans                   
29: R15         Goodwill and Other Intangible Assets                HTML    105K 
30: R16         Deposits                                            HTML     73K 
31: R17         Federal Home Loan Bank Advances, Other Borrowings   HTML     94K 
                and Subordinated Notes                                           
32: R18         Junior Subordinated Debentures                      HTML    109K 
33: R19         Segment Information                                 HTML    134K 
34: R20         Derivative Financial Instruments                    HTML    250K 
35: R21         Fair Values of Assets and Liabilities               HTML    407K 
36: R22         Stock-Based Compensation Plans                      HTML    145K 
37: R23         Shareholders' Equity and Earnings Per Share         HTML    155K 
38: R24         Regulatory Matters                                  HTML     93K 
39: R25         Basis of Presentation (Policies)                    HTML    195K 
40: R26         Business Combinations (Tables)                      HTML     50K 
41: R27         Investment Securities (Tables)                      HTML    331K 
42: R28         Loans (Tables)                                      HTML    125K 
43: R29         Allowance for Loan Losses, Allowance for Losses on  HTML   1.26M 
                Lending-Related Commitments and Impaired Loans                   
                (Tables)                                                         
44: R30         Goodwill and Other Intangible Assets (Tables)       HTML    103K 
45: R31         Deposits (Tables)                                   HTML     70K 
46: R32         Federal Home Loan Bank Advances, Other Borrowings   HTML     72K 
                and Subordinated Notes (Tables)                                  
47: R33         Junior Subordinated Debentures (Tables)             HTML     96K 
48: R34         Segment Information (Tables)                        HTML    126K 
49: R35         Derivative Financial Instruments (Tables)           HTML    222K 
50: R36         Fair Values of Assets and Liabilities (Tables)      HTML    383K 
51: R37         Stock-Based Compensation Plans (Tables)             HTML    137K 
52: R38         Shareholders' Equity and Earnings Per Share         HTML    142K 
                (Tables)                                                         
53: R39         Regulatory Matters (Tables)                         HTML     78K 
54: R40         Recent Accounting Developments (Narrative)          HTML     37K 
                (Details)                                                        
55: R41         Business Combinations (Summary of FDIC              HTML     49K 
                Indemnification Asset) (Detail)                                  
56: R42         Business Combinations (Narrative) (Detail)          HTML     86K 
57: R43         Investment Securities (Marketable Securities)       HTML     96K 
                (Detail)                                                         
58: R44         Investment Securities (Investment Securities,       HTML    106K 
                Continuous Unrealized Loss Position, Fair Value)                 
                (Detail)                                                         
59: R45         Investment Securities (Schedule of Realized Gain    HTML     50K 
                (Loss)) (Detail)                                                 
60: R46         Investment Securities (Investments Classified by    HTML     89K 
                Contractual Maturity Date) (Detail)                              
61: R47         Investment Securities (Narrative) (Detail)          HTML     44K 
62: R48         Loans (Summary of Loan Portfolio) (Detail)          HTML     68K 
63: R49         Loans (Schedule of Unpaid Principal Balance And     HTML     46K 
                Carrying Value Of Acquired Loans) (Detail)                       
64: R50         Loans (Certain Loans Acquired in Transfer Not       HTML     51K 
                Accounted for as Debt Securities Acquired During                 
                Period) (Details)                                                
65: R51         Loans (Activity Related to Accretable Yield of      HTML     56K 
                Loans Acquired With Evidence of Credit Quality                   
                Deterioration Since Origination) (Detail)                        
66: R52         Loans (Narrative) (Detail)                          HTML     47K 
67: R53         Allowance for Loan Losses, Allowance for Losses on  HTML    227K 
                Lending-Related Commitments and Impaired Loans                   
                (Schedule of Aging of the Company's Loan                         
                Portfolio) (Detail)                                              
68: R54         Allowance for Loan Losses, Allowance for Losses on  HTML    167K 
                Lending-Related Commitments and Impaired Loans                   
                (Summary of Performance by Loan Class) (Detail)                  
69: R55         Allowance for Loan Losses, Allowance for Losses on  HTML    120K 
                Lending-Related Commitments and Impaired Loans                   
                (Summary of Activity in the Allowance for Credit                 
                Losses) (Detail)                                                 
70: R56         Allowance for Loan Losses, Allowance for Losses on  HTML     50K 
                Lending-Related Commitments and Impaired Loans                   
                (Summary of Activity in the Allowance for Covered                
                Loan Losses) (Detail)                                            
71: R57         Allowance for Loan Losses, Allowance for Losses on  HTML     51K 
                Lending-Related Commitments and Impaired Loans                   
                (Summary of Impaired Loans, Including Restructured               
                Loans) (Detail)                                                  
72: R58         Allowance for Loan Losses, Allowance for Losses on  HTML    150K 
                Lending-Related Commitments and Impaired Loans                   
                (Summary of Impaired Loans by Loan Class) (Detail)               
73: R59         Allowance for Loan Losses, Allowance for Losses on  HTML    126K 
                Lending-Related Commitments and Impaired Loans                   
                (Summary of the Post-Modification Balance of TDRs)               
                (Detail)                                                         
74: R60         Allowance for Loan Losses, Allowance for Losses on  HTML     83K 
                Lending-Related Commitments and Impaired Loans                   
                (Summary of TDRs Subsequent Default Under the                    
                Restructured Terms) (Detail)                                     
75: R61         Allowance for Loan Losses, Allowance for Losses on  HTML     73K 
                Lending-Related Commitments and Impaired Loans                   
                (Narrative) (Detail)                                             
76: R62         Goodwill And Other Intangible Assets (Goodwill      HTML     55K 
                Assets by Business Segment) (Detail)                             
77: R63         Goodwill And Other Intangible Assets (Summary of    HTML     56K 
                Finite-Lived Intangible Assets) (Detail)                         
78: R64         Goodwill And Other Intangible Assets (Estimated     HTML     50K 
                Amortization) (Detail)                                           
79: R65         Goodwill And Other Intangible Assets (Narrative)    HTML     57K 
                (Detail)                                                         
80: R66         Deposits (Summary of Deposits) (Detail)             HTML     65K 
81: R67         Federal Home Loan Bank Advances, Other Borrowings   HTML     59K 
                and Subordinated Notes (Summary of Debt) (Details)               
82: R68         Federal Home Loan Bank Advances, Other Borrowings   HTML     62K 
                and Subordinated Notes (Summary of Pledged                       
                Securities Related to Securities Sold Under                      
                Repurchase Agreements) (Details)                                 
83: R69         Federal Home Loan Bank Advances, Other Borrowings   HTML    124K 
                and Subordinated Notes (Narrative) (Details)                     
84: R70         Junior Subordinated Debentures (Summary of Junior   HTML    135K 
                Subordinated Debentures) (Detail)                                
85: R71         Junior Subordinated Debentures (Narrative)          HTML     74K 
                (Detail)                                                         
86: R72         Segment Information (Summary of Segment             HTML    101K 
                Information) (Detail)                                            
87: R73         Segment Information (Narrative) (Detail)            HTML     41K 
88: R74         Derivative Financial Instruments (Interest Rate     HTML     72K 
                Cap Derivative Summary) (Detail)                                 
89: R75         Derivative Financial Instruments (Schedule Of Fair  HTML     78K 
                Value Of Derivative Financial Instruments)                       
                (Detail)                                                         
90: R76         Derivative Financial Instruments (Schedule Of Cash  HTML     65K 
                Flow Hedging Instruments) (Detail)                               
91: R77         Derivative Financial Instruments (Rollforward Of    HTML     45K 
                Amounts In Accumulated Other Comprehensive Income                
                Related To Interest Rate Swaps Designated As Cash                
                Flow Hedges) (Detail)                                            
92: R78         Derivative Financial Instruments (Derivatives Used  HTML     46K 
                To Hedge Changes In Fair Value Attributable To                   
                Interest Rate Risk) (Detail)                                     
93: R79         Derivative Financial Instruments (Summary Amounts   HTML     49K 
                Included In Consolidated Statement Of Income                     
                Related To Derivatives) (Detail)                                 
94: R80         Derivative Financial Instruments (Derivative Asset  HTML     81K 
                and Liability Balance Sheet Offsetting) (Detail)                 
95: R81         Derivative Financial Instruments (Narrative)        HTML     97K 
                (Detail)                                                         
96: R82         Fair Values Of Assets And Liabilities (Summary Of   HTML    114K 
                Balances Of Assets And Liabilities Measured At                   
                Fair Value On A Recurring Basis) (Detail)                        
97: R83         Fair Values Of Assets And Liabilities (Summary Of   HTML     60K 
                Changes In Level 3 Assets And Liabilities Measured               
                At Fair Value On A Recurring Basis) (Detail)                     
98: R84         Fair Values Of Assets And Liabilities (Summary Of   HTML     63K 
                Assets Measured At Fair Value On A Nonrecurring                  
                Basis) (Detail)                                                  
99: R85         Fair Values Of Assets and Liabilities (Schedule Of  HTML    122K 
                Valuation Techniques And Significant Unobservable                
                Inputs Used To Measure Both Recurring And                        
                Non-Recurring) (Detail)                                          
100: R86         Fair Values Of Assets And Liabilities (Summary Of   HTML    124K  
                Carrying Amounts And Estimated Fair Values Of                    
                Financial Instruments) (Detail)                                  
101: R87         Fair Values Of Assets And Liabilities (Narrative)   HTML    108K  
                (Detail)                                                         
102: R88         Stock-Based Compensation Plans (Weighted Average    HTML     45K  
                Assumptions Used To Determine The Options Fair                   
                Value) (Detail)                                                  
103: R89         Stock-Based Compensation Plans (Summary Of Stock    HTML     80K  
                Option Activity) (Detail)                                        
104: R90         Stock-Based Compensation Plans (Summary Of Plans'   HTML     72K  
                Restricted Share And Performance-Vested Stock                    
                Award Activity) (Detail)                                         
105: R91         Stock-Based Compensation Plans (Narrative)          HTML     73K  
                (Detail)                                                         
106: R92         Shareholders' Equity And Earnings Per Share         HTML     65K  
                (Components Of Other Comprehensive Income (Loss))                
                (Detail)                                                         
107: R93         Shareholders' Equity And Earnings Per Share (Other  HTML     61K  
                Comprehensive Income Reclassified from AOCI)                     
                (Detail)                                                         
108: R94         Shareholders' Equity And Earnings Per Share         HTML     72K  
                (Computation Of Basic And Diluted Earnings Per                   
                Common Share) (Detail)                                           
109: R95         Shareholders' Equity And Earnings Per Share         HTML    101K  
                (Narrative) (Detail)                                             
110: R96         Regulatory Matters (Schedule Of Adjusted Total      HTML     51K  
                Risk Based Capital Ratios) (Detail)                              
111: R97         Regulatory Matters (Narrative) (Detail)             HTML     57K  
113: XML         IDEA XML File -- Filing Summary                      XML    225K  
112: EXCEL       IDEA Workbook of Financial Reports                  XLSX    197K  
 9: EX-101.INS  XBRL Instance -- wtfc-20160331                       XML  11.45M 
11: EX-101.CAL  XBRL Calculations -- wtfc-20160331_cal               XML    436K 
12: EX-101.DEF  XBRL Definitions -- wtfc-20160331_def                XML   1.43M 
13: EX-101.LAB  XBRL Labels -- wtfc-20160331_lab                     XML   3.06M 
14: EX-101.PRE  XBRL Presentations -- wtfc-20160331_pre              XML   1.95M 
10: EX-101.SCH  XBRL Schema -- wtfc-20160331                         XSD    310K 
114: ZIP         XBRL Zipped Folder -- 0001015328-16-000344-xbrl      Zip    630K  


‘EX-10.2’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  


WINTRUST FINANCIAL CORPORATION
NONQUALIFIED STOCK OPTION AGREEMENT
This Nonqualified Stock Option Agreement (the “Agreement”) is dated as of «Date» (the “Grant Date”), by and between Wintrust Financial Corporation, an Illinois corporation (the “Company”), and «First_Name» «Last_Name» (the “Participant”) and is governed by the terms of the Wintrust Financial Corporation Long-Term Incentive Program (the “Program”), which was adopted by the Compensation Committee (the “Committee”) of the Board of Directors of the Company under the Wintrust Financial Corporation 2015 Stock Incentive Plan (the “Plan”). Capitalized terms not defined herein shall have the meanings specified in the Program or the Plan.
1.    Award.
(a)     Subject to the terms of this Agreement, the Program and the Plan, the Company hereby grants to the Participant an Option to purchase an aggregate of «Target_Time_Vested_Stock_Options_Units» shares of the Company’s common stock, no par value (the “Common Stock”), at an exercise price of $XXX per share (the “Exercise Price”). The number of shares of Common Stock and the Exercise Price shall be subject to adjustment as provided in the Plan. It is understood that this Agreement is subject to the terms of the Program and Plan, to which reference is hereby made for a more detailed description of the terms to which the Option is subject and by which reference the Program and Plan are incorporated herein. The Program and the Plan shall control in the event there is any conflict between the Plan or Program and this Agreement and on such matters as are not contained in this Agreement.
(b)    The Option shall be null and void unless the Participant shall accept this Agreement by executing it in the space provided below and returning such execution copy to the Company within ninety (90) days following the Participant’s receipt of this Agreement.
2.    Vesting and Exercise. (a) Subject to the terms of this Agreement, the Option shall vest and become exercisable as follows:
Date                            33.3%
Date                            33.3%
Date                            33.4%

(b) Unless otherwise permitted by the Committee under the terms of the Program or Plan, during the lifetime of the Participant, the Option may be exercised only by the Participant. Subject to the terms and conditions of this Agreement, the Option shall be exercisable by delivery of written notice of exercise accompanied by payment of the Exercise Price and any applicable tax withholding either (i) in cash, (ii) by delivery to the Company (either actual delivery or by attestation procedures established by the Company) of shares of Common Stock having an aggregate Fair Market Value, determined as of the date of exercise, equal to the aggregate purchase price and taxes payable pursuant to the Option by reason of such exercise, (iii) by authorizing the Company to withhold whole shares of Common Stock which would otherwise be delivered having an aggregate Fair Market Value, determined as of the date of




 
1



exercise, equal to the amount necessary to satisfy such obligation, (iv) except as may be prohibited by applicable law, in cash by a broker-dealer acceptable to the Company to whom Participant has submitted an irrevocable notice of exercise or (v) by a combination of (i), (ii) and (iii). Any fraction of a share of Common Stock which would be required to pay such exercise price and tax withholding shall be disregarded and the remaining amount due shall be paid in cash by the Participant.
(c)    Upon (i) a Change of Control or (ii) the termination of the Participant’s employment by the Company without Cause or by the Participant due to a Constructive Termination within 18 months following the occurrence of a Change of Control, the Option shall be governed by the terms of Sections 12(a) and 12(b) of the Plan, as applicable.
(d)    Unless earlier terminated hereunder or under the Plan, the Option shall expire on the seventh anniversary of the Grant Date (the “Expiration Date”).
3.    Termination of Employment. The Option shall be vested and exercisable following a termination of the Participant’s employment according to the following terms and conditions:
(a)    Termination by Reason of Death or Permanent Disability. In the event the employment of the Participant is terminated by reason of the Participant’s death or Permanent Disability, then the Option shall be 100% vested upon the effective date of such termination of employment and the Option may thereafter be exercised by the Participant or the Participant’s executor, administrator, legal representative, guardian or similar person until and including the earlier to occur of (i) the date which is one year after the date of such termination of employment and (ii) the Expiration Date.
For purposes of this Agreement, “Permanent Disability” shall mean any mental or physical illness, disability or incapacity that renders the Participant unable to perform his/her duties where a) such Permanent Disability has been determined to exist by a physician selected by the Company or b) the Company has reasonably determined, based on such physician’s advice, that such disability will continue for 180 days or more within any 365-day period, of which at least 90 days are consecutive. The Participant shall cooperate in all respects with the Company if a question arises as to whether he/she has become disabled (including, without limitation, submitting to an examination by a physician or other health care specialist selected by the Company and authorizing such physician or other health care specialist to discuss the Participant’s condition with the Company).
(b)    Termination by Reason of Retirement. In the event the employment of the Participant is terminated by reason of Retirement, then the Option, to the extent vested on the date of such termination of employment, may thereafter be exercised by the Participant until and including the earlier to occur of (i) the date which is one year after the date of such termination of employment and (ii) the Expiration Date. The portion of the Option that was not vested immediately prior to such termination of employment shall terminate immediately upon such termination of employment.






 
2



For purposes of this Agreement, “Retirement” shall mean the termination of a Participant’s employment for any reason other than death, disability or termination for Cause if it occurs on or after age 65 or on or after age 55 and, as of the date of termination, the sum of the Participant’s attained age as of his/her most recent birthday and the full and completed years of service with the Company (including continuous years of service, if any, with a subsidiary as of the date such subsidiary was acquired by the Company) equals or exceeds 75.
(c)    Termination by the Company without Cause or Voluntary Termination by the Participant. In the event the employment of the Participant is terminated by reason of the Company’s termination of the Participant’s employment without Cause or the Participant’s voluntary termination of employment for any reason other than due to death, Permanent Disability or Retirement, then the Option, to the extent vested on the date of such termination of employment, may thereafter be exercised by the Participant until and including the earlier to occur of (i) the date which is 90 days after the date of such termination of employment and (ii) the Expiration Date. The portion of the Option that was not vested immediately prior to such termination of employment shall terminate immediately upon such termination of employment.
(d)    Termination by the Company for Cause. In the event the employment of the Participant is terminated by the Company for Cause, then the Option, whether or not vested, shall terminate immediately upon such termination of employment.
(e)    Leave of Absence. During any paid or Company-approved unpaid leave of absence, the Option shall continue to vest during such leave of absence, provided that the Participant continues to remain an employee of the Company or one of its Affiliates.
4.    Non-Solicitation. The Participant understands and acknowledges that the Company and its Affiliates (collectively, “Wintrust”), has expended and continues to expend significant time and resources in recruiting, training and retaining Participant and its employees and in the development of valuable business relationships with its consultants and agents, the loss of which would cause significant and irreparable harm to Wintrust. During Participant’s employment with Wintrust and for twelve (12) months thereafter, Participant agrees and covenants not to directly or indirectly hire, solicit, induce or attempt to hire, solicit or induce any employee, consultant, or agent of Wintrust (i) to terminate such person’s employment or association with Wintrust or (ii) to become employed by or serve in any capacity by a bank or other financial institution which operates or is planned to operate at any facility which is located within a ten mile radius of any principal office or branch office of Wintrust. This restriction shall not prohibit Participant from hiring a Wintrust employee, consultant or agent in response to a general solicitation to the public. The restrictive covenants in this Agreement are in addition to and do not supersede the restrictive covenants in any other agreement Participant may have with Wintrust.
5.    Remedies. Participant acknowledges that compliance with the terms of this Agreement is necessary to protect Wintrust’s employment and business relationships and Wintrust’s goodwill and that any breach by Participant of this Agreement shall cause continuing and irreparable injury to Wintrust for which money damages would not be an adequate remedy. Participant acknowledges that the Company and its Affiliates are all intended beneficiaries of




 
3



this Agreement. Participant acknowledges that Wintrust shall be, in addition to any other rights or remedies it may have, entitled to injunctive relieve for any breach by Participant of any part of this Agreement. This Agreement shall not in any way limit the remedies available in law or equity to Wintrust.
6.    Transferability. The Option shall not be subject to execution, collateral assignment, attachment or similar process, unless otherwise permitted by the Committee under the terms of the Program or Plan. Any such attempted action or other disposition of the Option contrary to the provisions of the Program or Plan shall be null and void, and in such event the Company shall have the right to terminate the Option. Such termination shall not prejudice any rights or remedies which the Company or an Affiliate may have under this Agreement or otherwise.
7. Rights as a Shareholder. The Participant shall not be deemed for any purpose to be a shareholder of the Company with respect to any of the shares of Common Stock subject to the Option unless and until such shares are purchased and issued upon the exercise of the Option, in whole or in part, and the Participant becomes a shareholder of record with respect to such issued shares.
8.    Clawback Provision. Participant acknowledges that Participant has read the Company’s Clawback Policy. In consideration of the grant of the Option, the Participant agrees to abide by the Company’s Clawback Policy and any determinations of the Board pursuant to the Clawback Policy. Without limiting the foregoing, and notwithstanding any provision of this Agreement to the contrary, the Participant agrees that the Company shall have the right to require the Participant to repay the value of the Option as may be required by law (including, without limitation, the Dodd-Frank Wall Street Reform and Consumer Protection Act and implementing rules and regulations thereunder). This Section 8 shall survive the termination of the Participant’s employment for any reason. The foregoing remedy is in addition to and separate from any other relief available to the Company due to the Participant’s misconduct or fraud. Any determination by the Committee with respect to the foregoing shall be final, conclusive and binding upon the Participant and all persons claiming through the Participant.
9.    Notices. Each notice relating to this Agreement shall be in writing and delivered in person or by registered mail to Wintrust Financial Corporation, 9700 West Higgins Road, Rosemont, IL 60018, Attn: General Counsel, or at such other address designated by the Company. All notices to the Participant or other person or persons then entitled to exercise the Option shall be delivered to the Participant or such other person or persons at the Participant’s address as it then appears on the Company’s records.
10.    Administration. Any dispute or disagreement which shall arise under, as a result of, or in any way shall relate to the interpretation or construction or this Agreement shall be determined by the Committee or by the Board of Directors of the Company (or any successor corporation), and any such determination shall be final, binding and conclusive for all purposes.
11.    Governing Law. This agreement shall be governed by laws of the State of Illinois and shall inure to the benefit of and be binding upon the Company and its successors and assigns and the Participant and the Participant’s heirs, executors, administrators and successors.





 
4



Wintrust Financial Corporation by:


 
 
 
 
 
Date
 



Participant:


 
 
 
 
«First_Name» «Last_Name»
 
Date
 




Attest




 
 
 
 
David A. Dykstra
 
Date
 





 
5


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  Wintrust Financial Corp.          10-K       12/31/23  155:32M
 2/28/23  Wintrust Financial Corp.          10-K       12/31/22  152:35M
 2/25/22  Wintrust Financial Corp.          10-K       12/31/21  152:35M
 2/26/21  Wintrust Financial Corp.          10-K       12/31/20  157:36M
Top
Filing Submission 0001015328-16-000344   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 6:16:56.1am ET